ABBVIE DEUTSCHLAND GMBH & CO. KG
- J05 - Antivirales de uso sistémico
- EXVIERA film-coated tablet 250 mg
- KALETRA capsule, soft 133.3 mg+33.3 mg
- KALETRA film-coated tablet 100 mg+25 mg
- KALETRA film-coated tablet 200 mg+50 mg
- KALETRA oral solution 400 mg/5 ml+100 mg/5 ml
- MAVIRET film-coated tablet 100 mg+40 mg
- NORVIR film-coated tablet 100 mg
- NORVIR powder for oral suspension 100 mg
- VIEKIRAX film-coated tablet 12.5 mg+75 mg+50 mg
- L01 - Antineoplásicos
- TEPKINLY concentrate for solution for injection 4 mg/0.8 ml
- TEPKINLY solution for injection 48 mg/0.8 ml
- VENCLYXTO film-coated tablet 10 mg
- VENCLYXTO film-coated tablet 100 mg
- VENCLYXTO film-coated tablet 50 mg
- L04 - Inmunosupresores
- HUMIRA PREFILLED PEN solution for injection 40 mg/0.8 ml
- HUMIRA PREFILLED PEN solution for injection 80 mg/0.8 ml
- HUMIRA PREFILLED SYRINGE solution for injection 20 mg/0.2 ml
- HUMIRA PREFILLED SYRINGE solution for injection 40 mg/0.8 ml
- HUMIRA PREFILLED SYRINGE solution for injection 80 mg/0.8 ml
- RINVOQ prolonged-release tablet 15 mg
- RINVOQ prolonged-release tablet 30 mg
- SKYRIZI PREFILLED PEN solution for injection 150 mg/ml
- SKYRIZI PREFILLED SYRINGE solution for injection 150 mg/ml
- SKYRIZI PREFILLED SYRINGE solution for injection 75 mg/0.83 ml